Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Laporte

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymeraseMatthew G LaPorte, Tandy L Draper, Lori E Miller, et al.
Journal of Medicinal Chemistry|July 3, 2025
Antitumor Efficacy of 1,2,4-Triazole-Based VCP/p97 Allosteric InhibitorsNeal Green, Matthew G LaPorte, William Paquette, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Allosteric Indole Amide Inhibitors of p97: Identification of a Novel Probe of the Ubiquitin PathwayCeleste Alverez, Stacie L Bulfer, Ramappa Chakrasali, et al.
Communications Chemistry|August 9, 2024
Mechanism of allosteric inhibition of human p97/VCP ATPase and its disease mutant by triazole inhibitorsPurbasha Nandi, Kira DeVore, Feng Wang, et al.
ACS Medicinal Chemistry Letters|July 19, 2023
Optimization of 1,2,4-Triazole-Based p97 Inhibitors for the Treatment of CancerMatthew G LaPorte, Celeste Alverez, Alexander Chatterley, et al.
Molecular Cancer Therapeutics|February 25, 2014
Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft modelsChristopher A Benetatos, Yasuhiro Mitsuuchi, Jennifer M Burns, et al.
Journal of Medicinal Chemistry|April 2, 2014
Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignanciesStephen M Condon, Yasuhiro Mitsuuchi, Yijun Deng, et al.
Chemmedchem|August 30, 2008
The discovery of pyrano[3,4-b]indole-based allosteric inhibitors of HCV NS5B polymerase with in vivo activityMatthew G Laporte, Randy W Jackson, Tandy L Draper, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymeraseMatthew G LaPorte, Tandy L Draper, Lori E Miller, et al.
Journal of Medicinal Chemistry|July 3, 2025
Antitumor Efficacy of 1,2,4-Triazole-Based VCP/p97 Allosteric InhibitorsNeal Green, Matthew G LaPorte, William Paquette, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Allosteric Indole Amide Inhibitors of p97: Identification of a Novel Probe of the Ubiquitin PathwayCeleste Alverez, Stacie L Bulfer, Ramappa Chakrasali, et al.
Communications Chemistry|August 9, 2024
Mechanism of allosteric inhibition of human p97/VCP ATPase and its disease mutant by triazole inhibitorsPurbasha Nandi, Kira DeVore, Feng Wang, et al.
ACS Medicinal Chemistry Letters|July 19, 2023
Optimization of 1,2,4-Triazole-Based p97 Inhibitors for the Treatment of CancerMatthew G LaPorte, Celeste Alverez, Alexander Chatterley, et al.
Molecular Cancer Therapeutics|February 25, 2014
Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft modelsChristopher A Benetatos, Yasuhiro Mitsuuchi, Jennifer M Burns, et al.
Journal of Medicinal Chemistry|April 2, 2014
Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignanciesStephen M Condon, Yasuhiro Mitsuuchi, Yijun Deng, et al.
Chemmedchem|August 30, 2008
The discovery of pyrano[3,4-b]indole-based allosteric inhibitors of HCV NS5B polymerase with in vivo activityMatthew G Laporte, Randy W Jackson, Tandy L Draper, et al.
Pageof 5